
Portfolio
H1 2024 quality dividend portfolio review: cash income up 22%
Dividend income from my model portfolio continued to rise in Q2 and is on track for full-year growth. However, capital gains lagged the FTSE 100, leaving room for improvement.
Portfolio
Dividend income from my model portfolio continued to rise in Q2 and is on track for full-year growth. However, capital gains lagged the FTSE 100, leaving room for improvement.
Dividend share reviews
This 100-year-old business boasts enviable profitability and an impressive dividend track record. I hope it will provide me with more peace of mind than the stock I'm selling.
The Dividend Note
I review updates from FTSE 350 dividend shares WH Smith and B&M, plus struggling AIM engineer Gooch & Housego. Do any of them offer opportunities for my income portfolio?
Portfolio
The dividend stocks in my model portfolio produced five sets of results in May, including four from FTSE 100 companies.
The Dividend Note
This week I've reviewed the latest results from Impax Asset Management and Pets at Home - two distinctive UK dividend shares.
The Dividend Note
This week I've been taking a look at recent results from FTSE 250 dividend shares RS Group and Cranswick, plus news from investment platforms AJ Bell, Hargreaves Lansdown and IntegraFin.
Podcasts
Graham Neary, Mark Simpson and I discuss UK shares Property Franchise Group (& Belvoir), plus packaging group Macfarlane and groundworks specialist Van Elle Holdings.
The Dividend Note
Victrex and BT shares have both fallen out of favour with investors in recent years. But I reckon this week's results may provide some reasons for optimism.
Dividend share reviews
FTSE 250 stock Moneysupermarket.com Group (LON:MONY) offers 5%+ dividend yield backed by ample free cash flow. With a recovery seemingly underway, should I consider buying the shares for my dividend portfolio?
The Dividend Note
I review this week's updates from Direct Line Insurance, engineer Renishaw, and packaging group Macfarlane and ask if buying opportunities are emerging.
Portfolio
I review April updates from six of my portfolio companies, including a small-cap asset manager and two FTSE 100 dividend stocks.
The Dividend Note
I review full-year results from Premier Inn owner Whitbread and consider medical device specialist Smith & Nephew. Is either of these FTSE 100 dividend stocks a tempting buy?
Disclaimer: All content provided on this website is intended for educational and entertainment purposes only. This website does not provide investment advice or recommendations. You should research all investment decisions yourself and not rely upon information provided on this website. If you are unable to do this you should seek professional advice from a registered financial adviser.